Article
TREM2 variants and risk of Alzheimer's disease: a meta-analysis.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology - 1 Oct 2015
Lu Yanjun, Liu Wei, Wang Xiong
Abstract excerpt
Recent studies show that heterozygous variant of triggering receptor expressed on myeloid cells 2 (TREM2) increase the risk of Alzheimer's disease (AD) but with inconclusive results. Here, we conducted a meta-analysis to summarize and clarify the association between TREM2 variants and AD, and exa...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
